It's all a step in the right direction. Some real shareholders see the future, Why would that be? Answer: LERONLIMAB. Yes, AND real shareholders deserved a CRO that was not corrupted and did not tinker and withhold data. Is that too much to ask? CytoDyn is making vast improvements and the real INVESTORS can see it. Perhaps a little leronlimab for dementia would help to make it clearer why buying CytoDyn is the future..Yes, leronlimab to the rescue to block that CCR5 brain dysfunction. It was a good interview for some investors to learn the mechanism of action that separates leronlimab from some others and makes it totally unique. $CYDY$
Safe and Effective.
ps. lots of buying going on at these levels. Oh it is Friday already. Buh buy. All real investors will enjoy this weekend...another long one for me. Rock and Fire Cyrus.
Bullish